US Patent:
20120328565, Dec 27, 2012
Inventors:
John A. Brinkman - West Caldwell NJ, US
Andrew F. Donnell - West Windsor NJ, US
Robert Francis Kester - West Orange NJ, US
Yimin Qian - Wayne NJ, US
Ramakanth Sarabu - Towaco NJ, US
International Classification:
A61K 31/4178
C07D 417/14
C07D 401/14
C07D 487/04
C12N 5/071
A61K 31/4439
A61K 31/551
A61K 38/21
A61P 31/14
C07D 403/14
A61K 31/428
US Classification:
424 854, 5483147, 548178, 5462727, 540500, 514397, 514367, 514341, 514221, 435375
Abstract:
The present invention discloses compounds of Formula Iwherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the treatment of HCV infection.
